[HT-09] Hot Topics 09
Is the concept of embolic stroke of undertermined source (ESUS) dead or alive?

[HT-09-1] Problems of ESUS criteria from the viewpoint of the guidelines for implantable cardiac monitor

^○Keiji Yamaguchi (Department of Neurology, Ichinomiya Nishi Hospital, Japan)

Two clinical trials to compare direct oral anticoagulants (DOACs) and aspirin did not show superiority of DOACs over aspirin in patients with embolic stroke of undertermined source (ESUS). It is argued on the reasons for the negative results that covert atrial fibrilltion may not be a major cause and arteriogenic embolism may be prevalent than ever thought. In this symposium, we analyze the factors affecting the results, reconsider the the currrent concept of EUS, and perspect future direction of antithrombotic therapy.

Education:
1992Keio University School of Medicine, Tokyo, Japan, M.D.
Professional experience:
2018Vice-president and director, Department of Neurology, Ichinomiya Nishi Hospital
2012Director, Department of Neurology, Ichinomiya Nishi Hospital
2006 Director, Department of Neurology, Japanese Red Cross Mito Hospital
2005 Research Associate, Department of Neurology, Keio University School of Medicine
2002Research fellow, Department of Pathology and Laboratory Medicine, Indiana University School of Medicine
1999Research Associate, Department of Emergency Medicine, Keio University School of Medicine
1996Research Associate, Department of Neurology, Keio University School of Medicine
1995Medical staff, Department of Internal Medicine, National Hospital Organization Murayama Medical Center
1994Medical staff, Department of Internal Medicine, Saitama Municipal Hospital
1992Resident, Department of Internal Medicine, Keio University School of Medicine